Hospital
DLP Twin County Regional Healthcare LLC
DLP Twin County Regional Healthcare LLC was paid $18.87M by Medicaid between Jan 2018 and Dec 2024, across 229 billing codes. Its largest line is 99283, emergency room visit (moderate) — 16% of everything it billed.
33Billing provider infoDLP TWIN COUNTY REGIONAL HEALTHCARE LLC
GALAX, VA 24333
GALAX, VA 24333
33aNPI1114292141assigned 03/08/2012
33bProvider typeGeneral Acute Care Hospital
28Total paid$18.87M
24GClaims602,984
24DCodes billed229
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Virginia
Rank by total paid#34 of 80
Median peer was paid$14.69M
This provider vs. median1.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LAWRENCE, CHARLOTTE controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 75,592 | $1.52M | |
| 2019 | 108,009 | $2.63M | |
| 2020 | 80,978 | $2.49M | |
| 2021 | 86,927 | $2.58M | |
| 2022 | 78,035 | $2.69M | |
| 2023 | 94,254 | $3.63M | |
| 2024incomplete | 79,189 | $3.33M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 16% | 20,148 | 17,481 | $2.95M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 12% | 15,884 | 12,893 | $2.34M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 11% | 17,397 | 13,608 | $2.07M |
| 96361 | Intravenous infusion, hydration; each additional hour | 11% | 7,842 | 6,119 | $2.00M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 5.0% | 4,360 | 3,838 | $937K |
| 70450 | Computed tomography, head or brain; without contrast material | 3.8% | 5,348 | 4,459 | $715K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 3.6% | 3,236 | 2,777 | $675K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.6% | 10,381 | 2,671 | $492K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.6% | 2,936 | 2,605 | $481K |
| G0378 | Hospital observation service, per hour | 2.5% | 3,110 | 2,069 | $470K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 2.3% | 1,231 | 1,054 | $431K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.7% | 1,146 | 1,026 | $330K |
217 more codes
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.4% | 3,940 | $273K |
| 80053 | Comprehensive metabolic panel | 1.2% | 42,463 | $228K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 1.2% | 985 | $222K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 1.1% | 951 | $216K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.1% | 6,852 | $207K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1.0% | 4,482 | $197K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 1.0% | 4,216 | $197K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 1,484 | $183K |
| 59025 | Fetal non-stress test | <1% | 1,045 | $169K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 3,703 | $160K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 1,521 | $150K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 1,671 | $146K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 5,460 | $113K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 12,310 | $104K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 45,452 | $97K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 2,813 | $96K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 3,136 | $95K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 4,648 | $94K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 3,003 | $89K |
| 87070 | <1% | 9,919 | $85K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 2,294 | $81K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 1,924 | $80K |
| 74018 | <1% | 2,658 | $76K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 728 | $76K |
| 36415 | Collection of venous blood by venipuncture | <1% | 39,962 | $75K |
| 80061 | Lipid panel | <1% | 7,962 | $73K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 2,848 | $64K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 392 | $63K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 6,249 | $50K |
| 97161 | <1% | 465 | $47K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 13,419 | $39K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 102 | $38K |
| 71045 | Radiologic examination, chest; single view | <1% | 12,097 | $38K |
| 80050 | General health panel | <1% | 117 | $35K |
| 72100 | <1% | 1,603 | $34K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 222 | $33K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 14,456 | $32K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 7,018 | $32K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 63 | $31K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 1,017 | $30K |
| 84439 | <1% | 3,028 | $30K | |
| 87400 | <1% | 2,629 | $29K | |
| 93971 | <1% | 339 | $29K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 45 | $29K |
| 83880 | <1% | 3,263 | $28K | |
| G0379 | Direct admission of patient for hospital observation care | <1% | 275 | $27K |
| 73562 | <1% | 1,810 | $26K | |
| 73630 | <1% | 1,697 | $25K | |
| 73610 | <1% | 1,552 | $24K | |
| 62323 | <1% | 70 | $24K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 167 | $22K |
| 97162 | <1% | 263 | $21K | |
| 82607 | <1% | 1,802 | $21K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 7,959 | $19K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 2,735 | $18K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 600 | $16K |
| 85027 | <1% | 3,970 | $16K | |
| 86140 | <1% | 2,391 | $14K | |
| 73130 | <1% | 1,083 | $14K | |
| 87186 | <1% | 4,493 | $14K | |
| 83735 | <1% | 8,317 | $14K | |
| 81025 | <1% | 3,952 | $13K | |
| 73030 | <1% | 931 | $12K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 992 | $11K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 9,720 | $11K |
| 90715 | <1% | 750 | $11K | |
| 81001 | <1% | 15,907 | $10K | |
| 97150 | Therapeutic procedure(s), group (2 or more individuals) | <1% | 181 | $10K |
| 73110 | <1% | 723 | $10K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 11,127 | $9K |
| 87040 | <1% | 2,328 | $9K | |
| 85378 | <1% | 2,214 | $8K | |
| 84484 | <1% | 10,860 | $8K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 94 | $8K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 30 | $8K |
| 85610 | <1% | 5,677 | $8K | |
| 87088 | <1% | 4,008 | $8K | |
| 76770 | <1% | 71 | $7K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 55 | $7K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 407 | $7K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 410 | $7K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 49 | $7K |
| 97010 | <1% | 208 | $6K | |
| 70496 | <1% | 25 | $6K | |
| 0002A | <1% | 166 | $6K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 26 | $5K |
| 73502 | <1% | 393 | $5K | |
| 12001 | <1% | 32 | $5K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 337 | $5K |
| 97533 | <1% | 235 | $5K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 45 | $5K |
| 0001A | <1% | 164 | $5K | |
| 83540 | <1% | 894 | $4K | |
| 85652 | <1% | 1,855 | $4K | |
| 82746 | <1% | 530 | $4K | |
| 76642 | <1% | 39 | $4K | |
| 80165 | <1% | 763 | $4K | |
| 83690 | <1% | 9,181 | $4K | |
| 82728 | <1% | 249 | $4K | |
| 82150 | <1% | 4,803 | $4K | |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 75 | $3K |
| 81003 | <1% | 5,136 | $3K | |
| 85007 | <1% | 1,319 | $3K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 3,468 | $3K |
| 96376 | <1% | 1,571 | $3K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 26 | $3K |
| 96368 | <1% | 64 | $3K | |
| 83605 | <1% | 4,401 | $3K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,000 | $3K |
| 76536 | <1% | 27 | $3K | |
| 86850 | <1% | 752 | $3K | |
| 71250 | <1% | 70 | $3K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 4,128 | $3K |
| 74022 | <1% | 490 | $3K | |
| 99406 | <1% | 169 | $3K | |
| 84145 | <1% | 423 | $2K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 338 | $2K |
| 82962 | <1% | 1,567 | $2K | |
| 10060 | <1% | 15 | $2K | |
| 83550 | <1% | 312 | $2K | |
| 84702 | <1% | 535 | $2K | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 104 | $2K |
| 76830 | Ultrasound, transvaginal | <1% | 18 | $2K |
| 76801 | <1% | 26 | $2K | |
| 95806 | <1% | 15 | $2K | |
| 84436 | <1% | 209 | $2K | |
| 82140 | <1% | 555 | $2K | |
| 96367 | <1% | 39 | $2K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 7,339 | $1K |
| 85018 | <1% | 227 | $1K | |
| 86900 | <1% | 1,078 | $1K | |
| 85730 | <1% | 3,551 | $1K | |
| 82248 | <1% | 316 | $1K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 2,286 | $1K |
| 83655 | <1% | 86 | $1K | |
| 80076 | <1% | 238 | $1K | |
| 87486 | <1% | 50 | $1K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 6,211 | $1K |
| 82550 | <1% | 791 | $1K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 7,641 | $1K |
| 91300 | <1% | 96 | $1K | |
| 86901 | <1% | 1,127 | $1K | |
| 97014 | <1% | 40 | $1K | |
| 73590 | <1% | 83 | $948.29 | |
| 73090 | <1% | 106 | $934.83 | |
| 92508 | Group treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 17 | $882.64 |
| 73080 | <1% | 103 | $855.98 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,971 | $851.52 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 49 | $812.06 |
| 87581 | <1% | 49 | $812.06 | |
| 84703 | <1% | 2,198 | $753.59 | |
| 93017 | <1% | 30 | $727.66 | |
| 77080 | <1% | 14 | $698.03 | |
| 87205 | <1% | 313 | $632.13 | |
| J3490 | Unclassified drugs | <1% | 525 | $629.44 |
| 0004A | <1% | 20 | $623.83 | |
| 36600 | <1% | 610 | $596.52 | |
| 74220 | <1% | 14 | $596.47 | |
| 87807 | <1% | 328 | $556.21 | |
| 87077 | <1% | 239 | $555.36 | |
| J2800 | Injection, methocarbamol, up to 10 ml | <1% | 364 | $533.94 |
| 86803 | <1% | 41 | $476.57 | |
| 88312 | <1% | 1,355 | $457.80 | |
| 81015 | <1% | 2,762 | $456.97 | |
| 72050 | <1% | 31 | $450.32 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 3,044 | $418.48 |
| 84479 | <1% | 79 | $411.40 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 141 | $379.66 |
| 88304 | <1% | 108 | $320.50 | |
| 51701 | <1% | 212 | $309.98 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 3,564 | $287.87 |
| 82805 | <1% | 618 | $251.10 | |
| 87147 | <1% | 36 | $181.46 | |
| 82272 | <1% | 253 | $172.23 | |
| 73140 | <1% | 13 | $166.04 | |
| 71101 | <1% | 13 | $163.32 | |
| 82553 | <1% | 45 | $159.88 | |
| 82247 | <1% | 40 | $156.25 | |
| 97163 | <1% | 28 | $150.62 | |
| 97116 | <1% | 35 | $150.62 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,462 | $149.44 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 1,041 | $118.72 |
| 88313 | <1% | 706 | $113.75 | |
| 36416 | <1% | 137 | $102.15 | |
| 82570 | <1% | 38 | $101.04 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 1,074 | $96.72 |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | <1% | 31 | $91.12 |
| 84550 | <1% | 26 | $87.03 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 665 | $78.66 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 1,219 | $78.54 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,237 | $75.49 |
| 84153 | <1% | 14 | $68.44 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 504 | $37.85 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 825 | $30.09 |
| J2704 | Injection, propofol, 10 mg | <1% | 3,770 | $29.52 |
| 82565 | <1% | 20 | $11.03 | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 158 | $10.56 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 262 | $10.28 |
| 51702 | <1% | 83 | $8.34 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 212 | $7.03 |
| 82009 | <1% | 33 | $6.77 | |
| 84156 | <1% | 19 | $5.53 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 0% | 105 | $0.00 |
| 77003 | 0% | 37 | $0.00 | |
| 00731 | 0% | 14 | $0.00 | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 0% | 33 | $0.00 |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | 0% | 14 | $0.00 |
| J0153 | Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 0% | 14 | $0.00 |
| A9270 | Non-covered item or service | 0% | 3,964 | $0.00 |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 0% | 130 | $0.00 |
| J3480 | Injection, potassium chloride, per 2 meq | 0% | 34 | $0.00 |
| J2470 | Injection, pantoprazole sodium, 40 mg | 0% | 33 | $0.00 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 0% | 32 | $0.00 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 0% | 13 | $0.00 |
| 70498 | 0% | 13 | $0.00 | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 0% | 30 | $0.00 |
| 00813 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLAWRENCE, CHARLOTTE (SECRETARY)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.